Earnings summaries and quarterly performance for NASDAQ.
Executive leadership at NASDAQ.
Adena Friedman
Detailed
Chair and Chief Executive Officer
CEO
BP
Bradley Peterson
Detailed
Executive Vice President and Chief Information Officer/Chief Technology Officer
BS
Bryan Smith
Detailed
Executive Vice President and Chief People Officer
JS
Jeremy Skule
Detailed
Executive Vice President and Chief Strategy Officer; Executive Chair, Financial Crime Management Technology
JZ
John Zecca
Detailed
Executive Vice President and Chief Legal, Risk and Regulatory Officer
MD
Michelle Daly
Detailed
Senior Vice President and Controller and Principal Accounting Officer
NG
Nelson Griggs
Detailed
President
SY
Sarah Youngwood
Detailed
Executive Vice President and Chief Financial Officer
TC
Tal Cohen
Detailed
President
Board of directors at NASDAQ.
AZ
Alfred Zollar
Detailed
Director
CB
Charlene Begley
Detailed
Director
EK
Essa Kazim
Detailed
Director
HS
Holden Spaht
Detailed
Director
JY
Jeffery Yabuki
Detailed
Director
JT
Johan Torgeby
Detailed
Director
KK
Kathryn Koch
Detailed
Director
MA
Melissa Arnoldi
Detailed
Director
MS
Michael Splinter
Detailed
Lead Independent Director
TK
Thomas Kloet
Detailed
Director
TT
Toni Townes-Whitley
Detailed
Director
Research analysts who have asked questions during NASDAQ earnings calls.
Alexander Blostein
Goldman Sachs
8 questions for NDAQ
Also covers: AB, AMG, AMP +31 more
Brian Bedell
Deutsche Bank
7 questions for NDAQ
Also covers: AMG, AMTD, APO +23 more
Michael Cyprys
Morgan Stanley
7 questions for NDAQ
Also covers: AAMI, AMP, AMTD +30 more
Ashish Sabadra
RBC Capital Markets
6 questions for NDAQ
Also covers: ADP, CBOE, CLVT +20 more
Benjamin Budish
Barclays PLC
6 questions for NDAQ
Also covers: AB, APO, ARES +24 more
OL
Owen Lau
Oppenheimer & Co. Inc.
6 questions for NDAQ
Also covers: BLSH, CLVT, CME +9 more
PM
Patrick Moley
Piper Sandler & Co.
6 questions for NDAQ
Also covers: BGC, CBOE, CME +17 more
AK
Alex Kramm
UBS Group AG
5 questions for NDAQ
Also covers: BR, CBOE, CBRE +15 more
DF
Dan Fannon
Jefferies & Company Inc.
5 questions for NDAQ
Also covers: AB, AMG, AMTD +25 more
JS
Jeff Schmitt
William Blair & Company, L.L.C.
5 questions for NDAQ
Also covers: AIZ, AMP, FRGE +9 more
MC
Michael Cho
JPMorgan Chase & Co.
5 questions for NDAQ
Also covers: ENV, FHI, FRGE +4 more
EA
Eli Abboud
Bank of America
4 questions for NDAQ
Also covers: BGC, CBOE, CME +2 more
SC
Simon Clinch
Redburn Atlantic
4 questions for NDAQ
Also covers: CME, EFX, FICO +4 more
Craig Siegenthaler
Bank of America
3 questions for NDAQ
Also covers: AB, AMP, AMTD +26 more
DF
Daniel Fannon
Jefferies Financial Group Inc.
3 questions for NDAQ
Also covers: AB, AMG, AMTD +27 more
Kyle Voigt
Keefe, Bruyette & Woods
3 questions for NDAQ
Also covers: AMTD, APO, ARES +17 more
AK
Alexander Kramm
UBS Group AG
2 questions for NDAQ
WK
William Katz
TD Cowen
2 questions for NDAQ
Also covers: AB, AMG, AMTD +25 more
YC
Y. Cho
JPMorgan Chase & Co.
2 questions for NDAQ
Also covers: LPLA
Ben Budish
Barclays PLC
1 question for NDAQ
Also covers: AB, APO, ARES +23 more
Brian Bertram Bedell
Deutsche Bank AG
1 question for NDAQ
CA
Christopher Allen
Citigroup
1 question for NDAQ
Also covers: CBOE, CME, ETOR +9 more
JS
Jeffrey Schmitt
William Blair
1 question for NDAQ
Also covers: AIZ, AMP, CBOE +8 more
KS
Kwun Sum Lau
Oppenheimer
1 question for NDAQ
Also covers: CBOE, CLVT, CME +9 more
SA
Simon Alistair Clinch
Redburn Atlantic
1 question for NDAQ
Also covers: CME, EFX, FICO +3 more
Recent press releases and 8-K filings for NDAQ.
SVF Vaccines and Novakand Pharma enter reverse acquisition agreement
NDAQ
M&A
- SVF Vaccines’s portfolio company Novakand Pharma will acquire all SVF shares via issuance of new shares valued at SEK 55 million, subject to extraordinary general meeting approval, Nasdaq listing continuation and regulatory approval.
- Post-transaction, SVF shareholders will own 66.7% and Novakand shareholders 33.3% of the combined entity, which is targeted to list on Nasdaq First North in Q1 2026.
- The merged company will focus on SVF’s vaccine therapies, retain Novakand’s fractalkine program, and expects sufficient working capital for 12 months plus a planned SEK 30 million capital raise for a Phase 1 study.
19 hours ago
Nasdaq proposes fast-entry rule for large-cap IPOs
NDAQ
Delisting/Listing Issues
- Nasdaq proposed a “Fast Entry” rule to speed inclusion of newly listed large-cap companies into the Nasdaq-100, allowing eligible firms to join after 15 trading days with at least five trading days’ notice and waiving seasoning and some liquidity tests.
- Eligibility is based on a company’s market-capitalization ranking (roughly the top 40 of current constituents), with fast entrants temporarily expanding the index until the next annual reconstitution.
- The proposal includes technical tweaks to market-cap calculations, low-float weighting, and quarterly maintenance to enhance replicability for passive managers.
- Advisers for high-profile IPO candidates, including SpaceX (last valued at $800 billion) and AI startups like Anthropic, have engaged index providers about earlier entry, underscoring industry pressure for real-time market alignment.
- If approved, the changes could take effect after the March quarterly rebalance, prompting quicker rebalancing by index-tracking funds such as Invesco’s QQQ.
2 days ago
Bond lists on Nasdaq under ticker OBAI
NDAQ
Delisting/Listing Issues
- Bond (legal name Tg-17, Inc.) began trading on Nasdaq under the ticker OBAI, marking its public debut of the AI-powered Preventative Personal Security platform.
- The platform has handled over 1.4 million security service requests, including more than 10,000 emergencies and life-saving situations.
- With over $100 million invested in technology and operations, Bond targets a $438 billion global private security market as demand for proactive safety accelerates.
- The listing is positioned as a catalyst for long-term global growth and infrastructure expansion, rather than an exit event.
- Operating in 28 countries, Bond is already adopted by leading corporations, municipalities, and academic institutions worldwide.
3 days ago
Nasdaq partners with Osaka Exchange on next-generation derivatives platform
NDAQ
Product Launch
New Projects/Investments
- The Osaka Exchange selected Nasdaq Eqlipse Trading and Market Surveillance platforms to upgrade its derivatives infrastructure for enhanced performance and scalability.
- The deployment offers ultra-low latency, multi-asset trading support, robust risk management tools, and AI-driven market abuse detection to bolster market integrity.
- This expansion builds on Nasdaq’s longstanding technology partnerships across Japan’s financial ecosystem, including Calypso, AxiomSL, and Trade Surveillance solutions.
- The initiative aims to strengthen Japan’s position in the global derivatives market by future-proofing operations and enabling rapid product deployment.
3 days ago
Nasdaq shareholder update on merger investigations
NDAQ
M&A
Legal Proceedings
- Brodsky & Smith is investigating whether the Northfield Bancorp Board breached fiduciary duties in its $597 million stock-and-cash deal with Columbia Financial.
- An inquiry targets the Coterra Energy merger into Devon Energy at a 0.70 exchange ratio, implying a $58 billion enterprise value.
- The Exact Sciences Board’s approval of Abbott’s $105 per share cash offer (≈$21 billion equity value) is under review.
- The Semrush acquisition by Adobe for $12 per share (≈$1.9 billion) is examined, noting the deal price is below its 52-week high of $18.74.
3 days ago
Bond to Go Public on Nasdaq
NDAQ
Delisting/Listing Issues
- Registration statement declared effective by the SEC; trading on Nasdaq expected to begin February 4, 2026 under the ticker OBAI.
- Bond’s AI-powered Preventative Personal Security platform has handled 1.4 million service requests, including over 10,000 emergencies and life-saving interventions.
- The private security market is projected to reach $438 billion, positioning Bond as a potential category leader.
- Bond has invested more than $100 million to date in its technology, operations, and global expansion.
4 days ago
Nasdaq cites Omdia forecast: Retailers to control 47% of North American TV OS market by 2029
NDAQ
Guidance Update
- Omdia forecasts retailers will control 47% of the North American TV operating system market by 2029, up from 27% in 2025, driven by shifts in retail media ad strategies on smart TVs.
- In China, local platform Anesis maintains a 96% market share, with Omdia expecting this dominance to remain stable through the forecast period.
- Walmart’s CastOS shipments are projected to grow from 4.8 million units in 2024 to 6.6 million in 2025 (+37.5%) and reach 14 million units by 2027, reflecting momentum from its Vizio acquisition.
- Amazon’s Fire TV shipments rose from 6.1 million in 2024 to an expected 6.8 million in 2025 (+11.5%) and are forecast to hit 8.8 million by 2029, with total retail device shipments reaching 50 million units by 2029.
4 days ago
NASDAQ Private Shares Fund names SpaceX largest holding
NDAQ
New Projects/Investments
- SpaceX represents 13.64% of Private Shares Fund’s portfolio as of December 31, 2025, maintaining its position as the Fund’s largest holding
- The Fund’s top 10 positions account for 47.60% of total assets as of December 31, 2025, including SpaceX, GrubMarket, Nanotronics, Tradeshift, Dataminr, Motive Technologies, Databricks, xAI, EquipmentShare, and Upgrade
- Motive Technologies (3.79% weighting) confidentially filed for an IPO in September 2025 and publicly on January 5, 2026, with JPMorgan leading after a $150 million pre-IPO round
- EquipmentShare (2.82% weighting) filed its Form S-1 in December 2025 and debuted on Nasdaq under ticker EQPT on January 23, 2026
4 days ago
Check-Cap advances MBody AI merger with F-1 filing
NDAQ
M&A
- Filed Form F-1 registering shares for an equity line with ARC Group, enabling up to $30 million in discretionary growth capital.
- Furnished audited MBody AI financials for the year ended December 31, 2024 and six months ended June 30, 2025, reflecting a platform-building phase and commercial inflection in H2 2025 as deployments scaled.
- Returned to compliance with Nasdaq listing requirements and advanced the merger, expected to close in the first half of 2026, positioning the combined company as a leader in embodied AI.
5 days ago
ARS Pharma’s EURneffy® 1 mg recommended for EU approval for pediatric anaphylaxis
NDAQ
Product Launch
- The EMA’s CHMP adopted a positive opinion recommending EU marketing authorization of EURneffy® 1 mg for emergency treatment of Type I allergic reactions, including anaphylaxis, in children weighing ≥15 kg to <30 kg.
- This follows the 2 mg dose approved in August 2024 for patients ≥30 kg; upon EC approval, ALK-Abelló A/S will distribute EURneffy across the EU, Iceland, Liechtenstein, and Norway.
- The needle-free nasal spray addresses barriers to timely treatment in younger children—who account for one-quarter of epinephrine auto-injector use in Europe—potentially expanding market reach.
5 days ago
Fintool News
In-depth analysis and coverage of NASDAQ.
Quarterly earnings call transcripts for NASDAQ.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more